Research across Age-Related Macular Degeneration
Related studies from across the Age-Related Macular Degeneration family.
Stereotactic radiotherapy combined with ranibizumab for neovascular age-related macular degeneration shows potential cost benefits
Radiotherapy Shows Potential Cost Savings for Macular Degeneration Patients
Researchers evaluated the impact of stereotactic radiotherapy alongside ranibizumab for patients with neovascular age-related macular degene…
A trial suggests that adding stereotactic radiotherapy to standard care may lower healthcare costs and help track quality of life in macular…
Photobiomodulation protocol aims to consolidate preclinical evidence for ophthalmic diseases
Planning to Review Light Therapy for Common Eye Diseases and Injuries
This is a protocol for a systematic review and meta-analysis, not a completed study. It outlines plans to evaluate photobiomodulation (PBM) …
Experts are planning a large review to see if light therapy can help treat common eye problems like glaucoma and vision loss.
Marine compounds from Mexican Pacific Sargassum may protect against AMD progression in preclinical models
Marine compounds from seaweed may protect eyes from age-related degeneration
This narrative review examines marine-derived bioactive compounds from Mexican Pacific Sargassum, including fucoxanthin, fucoidans, phlorota…
Scientists are exploring how specific compounds found in Mexican Pacific seaweed could slow the progression of age-related macular degenerat…
Central 2.50-mm geographic atrophy extent correlates with visual function measures in age-related macular degeneration
Central vision loss impacts daily life for geographic atrophy patients
This observational analysis of Phase III clinical trial data involved 856 individuals aged 50 years or more with bilateral geographic atroph…
New analysis shows that damage in the very center of the eye most affects how people with geographic atrophy experience their daily lives.
Gene therapy significantly reduces central subfield thickness in neovascular age-related macular degeneration
Gene Therapy Shows Potential to Reduce Swelling in Macular Degeneration
This meta-analysis of early-phase trials evaluates gene therapy for neovascular age-related macular degeneration. While a significant anatom…
New gene therapy research shows significant reduction in retinal swelling for patients with neovascular age-related macular degeneration.
Faricimab 6 mg every sixteen weeks outperforms aflibercept and ranibizumab in ARMD visual acuity
Faricimab shows better vision outcomes for age related macular degeneration
This meta-analysis of 8 studies involving 8458 study populations found that faricimab 6 mg every sixteen weeks showed superior effects on be…
A new treatment option for age related macular degeneration may offer better vision and thinner retinal tissue than current standard drugs.
Ranibizumab and bevacizumab show comparable short-term efficacy for macular edema in retinal vein occlusion
Eye Drug Comparison Shows Similar Vision Gains
This meta-analysis of 759 patients with RVO-ME found no significant difference between intravitreal ranibizumab and bevacizumab monotherapy …
Two common eye injections work equally well for swelling caused by retinal vein blockage, a new analysis finds.
CFH Y402H and ARMS2 A69S polymorphisms are associated with increased risk of age-related macular degeneration
Specific genes linked to higher risk of age related macular degeneration
This meta-analysis evaluates the association between specific genetic polymorphisms and age-related macular degeneration (AMD) risk. The ana…
New research identifies two specific genetic variations that significantly increase the risk of developing age-related macular degeneration.
Aflibercept 8 mg at extended intervals yields comparable outcomes to 2 mg regardless of severity
Higher doses of aflibercept show similar results for macular degeneration
This post hoc descriptive subgroup analysis of a randomized controlled trial involving 869 treatment-naže patients with neovascular age-rela…
A higher dose of aflibercept may offer the same vision benefits as lower doses for patients with neovascular age-related macular degeneratio…
Anti-VEGF plus corticosteroids improves BCVA and reduces edema recurrence in BRVO and CRVO
Combination therapy improves vision for patients with retinal vein occlusion
This meta-analysis of 2040 patients found that anti-VEGF plus corticosteroid combination therapy resulted in better BCVA (MD -0.09) and redu…
Adding corticosteroids to anti-VEGF injections can improve vision and reduce the need for frequent eye injections in certain retinal conditi…
Migraine patients may have an increased risk of neovascular age-related macular degeneration
Migraine patients may face higher risk of certain eye conditions
This narrative review examines the association between migraine and various retinal conditions, including retinal migraine and AMD. The auth…
New research highlights a link between migraines and age-related macular degeneration, potentially impacting long-term vision for many suffe…
One-off 16 Gray stereotactic radiotherapy reduces anti-VEGF injections but results in worse visual acuity
Radiation for wet AMD cuts injections but harms vision
This randomized controlled trial of 411 patients with neovascular age-related macular degeneration found that one-off 16 Gray stereotactic r…
A single dose of radiation reduced the number of eye injections needed for wet AMD, but patients ended up with worse vision after four years…